Log in

NASDAQ:ADVMAdverum Biotechnologies Earnings Date, Estimates & History

+0.20 (+0.96 %)
(As of 07/1/2020 04:00 PM ET)
Today's Range
Now: $21.08
50-Day Range
MA: $21.27
52-Week Range
Now: $21.08
Volume894,092 shs
Average Volume1.47 million shs
Market Capitalization$1.69 billion
P/E RatioN/A
Dividend YieldN/A


Adverum Biotechnologies (NASDAQ:ADVM) Earnings Information

Adverum Biotechnologies last announced its earnings results on May 28th, 2020. The biotechnology company reported ($0.31) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.27) by $0.04. Adverum Biotechnologies has generated ($1.01) earnings per share over the last year. Adverum Biotechnologies has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 13th, 2020 based off prior year's report dates.

Adverum Biotechnologies Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Adverum Biotechnologies (NASDAQ:ADVM) Earnings Estimates

2020 EPS Consensus Estimate: ($0.96)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20201($0.23)($0.23)($0.23)
Q2 20201($0.24)($0.24)($0.24)
Q3 20201($0.26)($0.26)($0.26)
Q4 20201($0.23)($0.23)($0.23)
Q1 20211($0.30)($0.30)($0.30)
Q2 20211($0.30)($0.30)($0.30)
Q3 20211($0.30)($0.30)($0.30)

Adverum Biotechnologies (NASDAQ ADVM) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
5/28/20203/31/2020($0.27)($0.31)($0.31)$0.46 millionTranscript
3/12/202012/31/2019($0.29)($0.29)($0.29)$0.38 millionTranscript
11/7/2019Q3($0.27)($0.25)($0.25)$0.48 million$0.25 millionListen
8/8/2019Q2 2019($0.31)($0.23)($0.23)$0.38 millionTranscript
5/8/2019Q1($0.2690)($0.23)($0.23)$0.27 millionN/A
3/6/2019Q4($0.2860)($0.25)($0.25)$0.39 million$0.07 millionN/A
11/8/2018Q3($0.2980)($0.34)($0.18)$0.27 million$0.83 millionN/A
8/8/2018Q2 2018($0.3070)($0.30)($0.30)$0.40 million$0.49 millionN/A
5/9/2018Q1($0.29)($0.30)($0.30)$0.40 million$0.22 millionN/A
3/6/2018Q4 2017($0.35)($0.32)($0.32)$0.46 millionN/A
11/8/2017Q3 2017($0.29)($0.32)($0.32)$0.46 millionN/A
8/8/2017Q2 2017($0.37)($0.27)($0.27)$0.46 millionN/A
5/9/2017Q1 2017($0.26)($0.38)($0.38)$0.46 millionN/A
3/6/2017Q4 2016($0.25)($0.27)$0.49 millionN/A
11/8/2016Q3 2016($0.29)($0.35)($0.35)$0.40 millionN/A
8/9/2016Q2 2016($0.38)($0.36)$1.04$0.31 millionN/A
5/6/2016Q116($0.39)($0.57)($0.57)$0.27 millionN/A
3/3/2016Q4($0.40)($0.45)($0.35)$0.20 million$0.96 millionN/A
11/9/2015Q3 2015($0.42)($0.55)($0.55)$0.20 million$0.95 millionN/A
8/13/2015Q215($0.37)($0.38)($0.38)$0.20 million$0.20 millionN/A
5/13/2015Q1 2015($0.42)($0.38)($0.38)$0.14 million$0.20 millionN/A
3/5/2015Q4 2014($0.33)($0.46)($0.46)$0.20 million$0.20 millionN/A
11/12/2014Q3 2014($0.15)($0.50)($0.50)$0.03 million$0.20 millionN/A
9/11/2014Q2 2014($0.51)($2.27)($2.27)$0.14 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 7/2/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.